
A normal screening result does not rule out future cancer, while an abnormal result does not confirm it. By following the right schedule for your age and risk, recognising symptoms that need diagnostic testing, and completing follow-up, you can use screening more effectively and avoid unnecessary tests.
Key takeaways
- Screening checks people without symptoms; diagnostic tests investigate abnormal findings.
- Family history, inherited risk, and past cancer can change when screening starts.
- A normal result lowers concern for that test—it does not prevent future cancer.
- An abnormal screen requires follow-up testing, not an assumption that you have cancer.
Screening, diagnostic testing and surveillance are different
Book cancer screening without symptoms when you reach the recommended age and risk-based interval; do not wait for cancer symptoms. Screening looks for disease in people who feel well, while an abnormal result leads to diagnostic testing, not an automatic cancer diagnosis.
- Routine screening: Follow the schedule for your age and risk level. A family history, a relative diagnosed young, several related cancers, or a BRCA1 or BRCA2 variant may require genetic counselling and an earlier or more intensive plan.
- Diagnostic testing: Seek prompt assessment for a new lump, abnormal bleeding, unexplained weight loss, or persistent bowel or bladder changes, even after a recent normal screen. Your clinician may order imaging, blood tests, endoscopy, or biopsy.
- Surveillance after treatment: Attend the follow-up plan set by your cancer team. Its visits and tests depend on the original cancer, treatment, recurrence risk, and treatment effects; it is not routine screening.
Complete follow-up after an abnormal screen. A negative result is not a lifetime guarantee, and commercially marketed multi-cancer blood tests have not replaced proven screening programmes.
A practical screening schedule for five common cancers
These intervals apply to average-risk adults without symptoms. Guidance differs by country; symptoms require diagnostic evaluation, not a routine screening appointment.
| Cancer | Start and repeat schedule |
|---|---|
| Breast | Mammography age 40 through 74, repeated every two years. |
| Cervical | Start at age 21 with a Pap test every three years until 29. From 30 to 65, choose cervical HPV testing every five years, co-testing every five years, or a Pap test interval of three years. |
| Colorectal | Screen from age 45 to 75. Options include FIT every year, stool DNA-FIT every one to three years, or colonoscopy every 10 years. A positive stool test requires colonoscopy. |
| Lung | Begin annual low-dose CT for adults from lung cancer screening age 50 to 80 who currently smoke or quit within 15 years and have at least a 20 pack-year history. Stop after 15 smoke-free years or if treatment would not be appropriate. |
| Prostate | There is no automatic schedule. Have a PSA testing discussion at ages 55 to 69, then decide whether testing and repeat testing every one to two years fit your preferences and risk. Do not start routine PSA screening at 70 or older. |
How family history and personal risk change the plan
A first-degree relative with cancer can move you out of average-risk screening, especially when diagnosis occurred young, several relatives developed related cancers, or one person had multiple cancers. Do not simply start routine screening earlier on your own; ask a clinician whether genetic counselling or intensified surveillance is appropriate.
| Factor | Why it changes the plan | What to discuss |
|---|---|---|
| Family history of colorectal cancer | Risk rises with an affected first-degree relative, particularly at a young age | Earlier colonoscopy or another risk-based schedule |
| Family history of breast or ovarian cancer | May indicate inherited risk, including BRCA1 and BRCA2 variants | Genetic counselling, earlier imaging, or breast MRI |
| Family history of prostate cancer | Risk depends on the relative’s age at diagnosis and how many relatives were affected | Earlier PSA discussion and an individual schedule |
| Previous polyps | Adenomatous or serrated polyps can require surveillance colonoscopy | The pathology report and recommended interval |
| Abnormal screening result | Follow-up depends on the test and result, not the average-risk timetable | Diagnostic testing or specialist review |
| Smoking history | A substantial smoking history can qualify you for annual low-dose CT lung screening | Eligibility, false positives, and smoking cessation |
What each screening test finds—and what it can miss
A screening test’s value depends on what it detects, what it misses, and what an abnormal result demands next.
| Test | Finds and can miss | Preparation, discomfort and follow-up |
|---|---|---|
| Mammogram | Finds many breast cancers; dense tissue can hide a tumour. A mammogram false positive leads to extra imaging or biopsy. | Brief breast compression; no sedation. Follow the imaging centre’s recall or biopsy plan. |
| Cervical HPV or Pap test | High-risk HPV can precede cervical cancer. An HPV positive result is not cancer; follow-up testing or colposcopy is needed. | Speculum examination may feel uncomfortable; no sedation. |
| Stool-based colorectal test | Detects blood or abnormal DNA, but can miss non-bleeding cancers and polyps. Any positive result requires colonoscopy. | Collect a home sample; no procedure discomfort unless follow-up is needed. |
| Colonoscopy | Directly views the colon and removes adenomatous polyps, preventing some cancers; small lesions can still be missed. | Colonoscopy bowel preparation, sedation, transport home and recovery time are required. |
| Low-dose CT | Finds early lung nodules in eligible smokers; low-dose CT false positives and incidental findings can trigger repeat scans or biopsy. | No bowel preparation or sedation; lie still briefly. Follow-up depends on nodule size and appearance. |
| PSA blood test | Can signal prostate cancer but also rises with benign enlargement or infection; PSA limitations include missed cancers and overdiagnosis. | Simple blood draw. Repeat testing, examination or biopsy depends on the result and risk. |
Why a regular schedule matters even after a normal result
A negative screening result lowers risk; it does not prove that cancer is absent forever. A tumour can develop after the test or remain too small to detect, becoming an interval cancer before the next scheduled round. Repeating screening at the recommended interval catches disease that timing missed.
No single scan or blood test checks every cancer because cancers arise in different organs, change at different rates, and release different detectable signals. Proven programmes target selected cancers and defined risk groups; a general annual scan is not an evidence-based substitute.
Commercially marketed multi-cancer early detection tests do not replace breast, cervical, colorectal, or lung screening. Finding a signal is not the same as reducing deaths, and false negatives can falsely reassure you while positive results can lead to invasive tests. Screening can also cause overdiagnosis: finding a slow-growing cancer that would never have harmed you.
Continue screening while its likely benefit outweighs its burden. Weigh life expectancy, major illnesses, treatment fitness, previous results, and preferences through shared decision-making. Symptoms require diagnostic evaluation even after a normal result.
What to do after an abnormal screening result
An abnormal screening result is a signal to investigate, not a cancer diagnosis. Contact the ordering clinician promptly and ask what confirmatory testing is needed; do not wait for the next routine screening date.
A new lump, unusual bleeding, unexplained weight loss, or persistent bowel or bladder change needs diagnostic evaluation even after a recent normal result.
The follow-up depends on the test:
- Abnormal mammogram follow-up may include extra mammographic views, breast ultrasound, or a biopsy.
- Positive HPV follow-up follows the cervical-screening result and risk category; it may involve repeat testing or colposcopy. A positive HPV result does not mean you have cervical cancer.
- A positive FIT requires colonoscopy. During it, the doctor can remove suspicious polyps and send tissue for examination.
- Diagnostic imaging or a biopsy may clarify an abnormal finding; imaging alone does not always confirm cancer.
Involve a specialist cancer team when biopsy confirms cancer, imaging strongly suggests it, or a complex abnormality needs coordinated decisions. An oncology referral supports staging and treatment planning; a cancer surgery consultation is appropriate when an operation could be part of treatment.
Dr Gawande Oncocare Centre can help coordinate these discussions after diagnostic evidence is available.
Frequently asked questions
What is the difference between screening, diagnostic testing, and surveillance?
Screening looks for cancer in people without symptoms. Diagnostic testing investigates symptoms or an abnormal screening result. Surveillance monitors you after cancer treatment or when you have a higher risk.
How often should you have screening for common cancers?
The schedule depends on the cancer type, your age, sex, family history, personal medical history, and previous results. Use the recommended interval for each test rather than waiting for symptoms.
How does family history change a cancer screening plan?
A close relative with cancer, several affected relatives, young age at diagnosis, or a known inherited mutation can require earlier or more frequent screening. Share the relative’s cancer type and age at diagnosis with your doctor.
What can cancer screening tests miss?
A screening test can miss a cancer that is too small, hidden, or outside the test’s detection range. A normal result does not rule out every cancer or replace evaluation of new symptoms.
What should you do after an abnormal cancer screening result?
Contact the clinician who ordered the test and ask which follow-up is needed. Diagnostic imaging, repeat testing, a biopsy, or specialist review may be recommended; an abnormal screen is not an automatic cancer diagnosis.






